Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Consulting agrmnt
Appointed director
|
|
SIGMA ADDITIVE SOLUTIONS, INC. (SGLB)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/13/2023 |
8-K
| Quarterly results |
| 10/13/2023 |
8-K
| Quarterly results |
| 10/10/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 08/22/2023 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and... |
| 08/14/2023 |
8-K
| Quarterly results|
Docs:
|
"AT-THE-MARKET ISSUANCE SALES AGREEMENT",
"TroyGould PC 1801 Century Park East, 16th Floor Los Angeles, California 90067",
"Sigma Additive Solutions Reports Second Quarter 2023 Financial Results SANTA FE, NM – August 14, 2023 – Sigma Additive Solutions, Inc. , a leading provider of quality assurance software to the commercial 3D printing industry, has reported its financial and operating results for the quarter ended June 30, 2023. Second Quarter 2023 Results Conference Call Due to discussions related to the Company’ s ongoing consideration of a range of strategic alternatives designed to enhance shareholder value, including a possible strategic investment, acquisition, merger, business combination, or similar transaction, Sigma is not hosting its regular quarterly conference call. Future material developments related to strategic alternatives will be publicly communicated to shareholders. Management Commentary..." |
|
| 08/14/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 08/14/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 07/20/2023 |
8-K
| Quarterly results |
| 06/16/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 04/18/2023 |
424B3
| Form 424B3 - Prospectus [Rule 424(b)(3)]: |
| 04/18/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 04/13/2023 |
8-K
| Quarterly results |
| 03/02/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 03/01/2023 |
8-K
| Quarterly results |
| 02/10/2023 |
S-3
| Form S-3 - Registration statement under Securities Act of 1933: |
| 01/27/2023 |
8-K
| Unregistered Sales of Equity Securities, Departure of Directors or Certain Officers; Election of Directors; Appointment of Ce... |
| 12/16/2022 |
8-K
| Quarterly results |
| 11/14/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 11/14/2022 |
8-K
| Quarterly results |
| 10/19/2022 |
8-K
| Quarterly results |
| 10/19/2022 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 09/22/2022 |
8-K
| Resignation/termination of a director |
| 08/12/2022 |
8-K
| Quarterly results |
| 08/05/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 08/05/2022 |
8-K
| Quarterly results |
| 07/08/2022 |
8-K
| Quarterly results |
| 07/06/2022 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 06/21/2022 |
PRE 14A
| Form PRE 14A - Other preliminary proxy statements: |
| 05/24/2022 |
8-K
| Quarterly results |
| 05/17/2022 |
8-K
| Quarterly results |
| 04/26/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
| 04/26/2022 |
8-K
| Quarterly results|
Docs:
|
"Sigma Labs, Inc. Condensed Balance Sheets December 31, 2021 ASSETS Current Assets: Cash $ 9,277,929 $ 11,447,047 Accounts Receivable, net 261,022 412,192 Inventory 782,099 710,080 Prepaid Assets 165,274 114,278 Total Current Assets 10,486,324 12,683,597 Other Assets: Property and Equipment, net 288,924 232,282 Intangible Assets, net 978,984 925,111 Total Other Assets 1,267,908 1,157,393 TOTAL ASSETS $ 11,754,232 $ 13,840,990 LIABILITIES AND STOCKHOLDERS’ EQUITY Current Liabilities: Accounts Payable $ 320,547 $ 206,442 Deferred Revenue 160,276 148,855 Accrued Expenses 416,643 625,942 Total Current Liabilities 897,466 981,239 TOTAL LIABILITIES 897,466 981,239 Stockholders’ Equity Preferred Stock, $0.001 par; 10,000,000 shares authorized; 465 shares issued and outstanding, respectively 1 1 Co..." |
|
| 04/14/2022 |
8-K
| Investor presentation |
| 04/04/2022 |
8-K
| Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and... |
|
|
|